A A A

2012

PUBLICATIES ALZHEIMERCENTRUM VUMC 2012

Internationale wetenschappelijke publicaties:

  • Bakker C, de Vugt ME, van VD, Verhey FR, Pijnenburg YA, Vernooy-Dassen MJ, Koopmans RT. The Use of Formal and Informal Care in Early Onset Dementia: Results From the NeedYD Study. Am J Geriatr Psychiatry 2012.
  • Calmels C, Foutren M, Stam CJ. Beta Functional Connectivity Modulation during the Maintenance of Motion Information in Working Memory: Importance of the Familiarity of the Visual Context. Neuroscience 2012.
  • Clerx L, Visser PJ, Verhey F, Aalten P. New MRI Markers for Alzheimer's Disease: A Meta-Analysis of Diffusion Tensor Imaging and a Comparison with Medial Temporal Lobe Measurements. J Alzheimers Dis 2012.
  • Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol 11: 170-8, 2012.
  • de Haan W, van der Flier WM, Koene T, Smits LL, Scheltens P, Stam CJ. Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's disease. Neuroimage 59: 3085-93, 2012.
  • de Haan W, van der Flier WM, Wang H, Van Mieghem PF, Scheltens P, Stam C. Disruption of functional brain networks in Alzheimer's disease: what can we learn from graph spectral analysis of resting-state MEG? Brain Connect 2012.
  • Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, Scahill RI, Tabrizi SJ, Ourselin S, Fox NC, Alexander DC. An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. Neuroimage 2012.
  • Frederiksen KS, Garde E, Skimminge A, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Baezner H, Verdelho A, Ferro JM, Erkinjuntti T, Jokinen H, Wahlund LO, O'Brien JT, Basile AM, Pantoni L, Inzitari D, Waldemar G. Corpus callosum tissue loss and development of motor and global cognitive impairment: the LADIS study. Dement Geriatr Cogn Disord 32: 279-86, 2011.
  • Frederiksen KS, Garde E, Skimminge A, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Baezner H, Verdelho A, Ferro JM, Erkinjuntti T, Jokinen H, Wahlund LO, O'Brien JT, Basile AM, Pantoni L, Inzitari D, Waldemar G. Corpus Callosum Tissue Loss and Development of Motor and Global Cognitive Impairment: The LADIS Study. Dement Geriatr Cogn Disord 32: 279-86, 2012.
  • Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kolsch H, Heun R, Schurmann B, Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O'Donovan MC, Owen MJ, Williams J. The Role of Variation at AbetaPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease. J Alzheimers Dis 28: 377-87, 2012.
  • Janzen J, van 't Ent D, Lemstra AW, Berendse HW, Barkhof F, Foncke EM. The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J Neurol 259: 147-54, 2012.
  • Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2: a006213, 2012.
  • Jokinen H, Frederiksen KS, Garde E, Skimminge A, Siebner H, Waldemar G, Ylikoski R, Madureira S, Verdelho A, van Straaten EC, Barkhof F, Fazekas F, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T. Callosal tissue loss parallels subtle decline in psychomotor speed. A longitudinal quantitative MRI study. The LADIS Study. Neuropsychologia 2012.
  • Joling KJ, Smit F, van Marwijk HW, van der Horst HE, Scheltens P, Schulz R, van Hout HP. Identifying target groups for the prevention of depression among caregivers of dementia patients. Int Psychogeriatr 24: 298-306, 2012.
  • Joling KJ, van Marwijk HW, Smit F, van der Horst HE, Scheltens P, van de Ven PM, Mittelman MS, van Hout HP. Does a family meetings intervention prevent depression and anxiety in family caregivers of dementia patients? A randomized trial. PLoS One 7: e30936, 2012.
  • Lehmann M, Barnes J, Ridgway GR, Ryan NS, Warrington EK, Crutch SJ, Fox NC. Global gray matter changes in posterior cortical atrophy: A serial imaging study. Alzheimers Dement 2012.
  • Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC. Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiol Aging 2012.
  • Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135: 736-50, 2012.
  • Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135: 736-50, 2012.
  • Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jager HR. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012.
  • Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde RM, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jonhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 2012.
  • Meesters PD, Comijs HC, Droes RM, de HL, Smit JH, Eikelenboom P, Beekman AT, Stek ML. The Care Needs of Elderly Patients With Schizophrenia Spectrum Disorders. Am J Geriatr Psychiatry 2012.
  • Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Sambuceti G, Pagani M, Salmon E, Nobili F. Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging 2012.
  • Olde Dubbelink KT, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Berendse HW. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging 2012.
  • Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Longitudinal imaging of Alzheimer pathology using [(11)C]PIB, [ (18)F]FDDNP and [ (18)F]FDG PET. Eur J Nucl Med Mol Imaging 2012.
  • Reeb-Sutherland BC, Levitt P, Fox NA. The predictive nature of individual differences in early associative learning and emerging social behavior. PLoS One 7: e30511, 2012.
  • Resnick SM, Scheltens P. MRI-based biomarkers of preclinical AD: An Alzheimer signature. Neurology 78: 80-1, 2012.
  • Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, Inzitari D, Barkhof F, Waldemar G. The spatial distribution of age-related white matter changes as a function of vascular risk factors-Results from the LADIS study. Neuroimage 2012.
  • Scheltens P, Goos JD. Dementia in 2011: Microbleeds in dementia-singing a different ARIA. Nat Rev Neurol 8: 68-70, 2012.
  • Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78: 47-54, 2012.
  • Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, de Graaf JR, de Koning I, van Schoor NM, Deeg DJ, Smits M, Raaphorst J, van den Berg LH, Schelhaas HJ, De Die-Smulders CE, Majoor-Krakauer D, Rozemuller AJ, Willemsen R, Pijnenburg YA, Heutink P, van Swieten JC. The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain 2012.
  • Smits LL, Pijnenburg YA, Koedam EL, van d, V, Reuling IE, Koene T, Teunissen CE, Scheltens P, van der Flier WM. Early Onset Alzheimer's Disease is Associated with a Distinct Neuropsychological Profile. J Alzheimers Dis 2012.
  • Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 2012.
  • Stam CJ, van Straaten EC. The organization of physiological brain networks. Clin Neurophysiol 2012.
  • van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, Comans EF, Hoetjes NJ, Tolboom N, Langer O, Muller M, Scheltens P, Lammertsma AA, van Berckel BN. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain 135: 181-9, 2012.
  • van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. P-Glycoprotein Function at the Blood-Brain Barrier: Effects of Age and Gender. Mol Imaging Biol 2012.
  • van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, van Berckel BN, Lammertsma AA. Reproducibility of quantitative (R)-[11C]verapamil studies. EJNMMI Res 2: 1, 2012.
  • van Dijk AM, van Weert JC, Droes RM. Does theatre improve the quality of life of people with dementia? Int Psychogeriatr 24: 367-81, 2012.
  • van Harten AE, Scheeren TW, Absalom AR. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia. Anaesthesia 67: 280-93, 2012.
  • van Mierlo LD, Meiland FJ, Droes RM. Dementelcoach: effect of telephone coaching on carers of community-dwelling people with dementia. Int Psychogeriatr 24: 212-22, 2012.
  • van Mierlo LD, Meiland FJ, Van der Roest HG, Droes RM. Personalised caregiver support: effectiveness of psychosocial interventions in subgroups of caregivers of people with dementia. Int J Geriatr Psychiatry 27: 1-14, 2012.
  • van Norden AG, van Dijk EJ, de Laat KF, Scheltens P, Olderikkert MG, de Leeuw FE. Dementia: Alzheimer pathology and vascular factors: From mutually exclusive to interaction. Biochim Biophys Acta 1822: 340-9, 2012.
  • van Rossum I, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P. Injury Markers but not Amyloid Markers are Associated with Rapid Progression from Mild Cognitive Impairment to Dementia in Alzheimer's Disease. J Alzheimers Dis 29: 319-27, 2012.
  • Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'italien G, van der Flier WM, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging 2012.
  • Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P. Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial. J Alzheimers Dis 29: 459-69, 2012.
  • Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P. Memantine and Brain Atrophy in Alzheimer's Disease: A 1-Year Randomized Controlled Trial. J Alzheimers Dis 2012.
  • Wouters H, Appels B, van der Flier WM, van CJ, Klein M, Zwinderman AH, Schmand B, van Gool WA, Scheltens P, Lindeboom R. Improving the accuracy and precision of cognitive testing in mild dementia. J Int Neuropsychol Soc 18: 314-22, 2012.